InferVision

Join Radiologist, Dr. Matthew Hoimes, and CIO, Matt Dewey, MMCi, from WakeRad UNC REX at the upcoming webinar “TeraRecon Insider Series: Wake Radiology” for their successful journey of AI adoption among the earliest radiology AI adopters in the nation: terarecon.zoom.us/webinar/regist…

Truly grateful for our amazing partners and clients along the way. Looking forward to 2021, Infervision will continue serving the medical community with our strong technology and passion for medical AI. We invite you to join us on this fantastic journey, and Happy New Year 2021!

Merry Christmas 2020 and A Happy New Year 2021 from Infervision

Thank you @SCMPResearch for recognizing Infervision as a dedicated case study in the newly published industry report. Check out more insights from SCMP's comprehensive 2020 Computer Vision Report: research.scmp.com/products/china…

Can AI software drive CT lung screening rates higher? Find out the insights at the talk between Infervision executives and @AuntMinnie Editor-in-Chief Brian Casey and Senior Editor Erik L. Ridley: bit.ly/3mH3PZZ

#RSNA20 Day 2 is here. We have representatives at our Infervision virtual booth 24/7 during the conference. Join us for a conversation at any time: bit.ly/Infervision-bo…

Virtual #rsna20 starts today (Nov 29th-Dec 5th)! Visit Infervision at the virtual booth bit.ly/Infervision-bo…, or set up a conversation with us right away bit.ly/Meet_Infervisi… to learn more about our FDA-cleared AI solutions for medical imaging professionals.

We invite you to join Infervision at the all-virtual #RSNA20 from Nov 29th – Dec 5th, 2020. Learn more about our FDA-cleared AI solution and how we can help your interpretation workflow. Book Meeting with us now: bit.ly/Meet_Infervisi… Join us virtually: bit.ly/joinInfervision

By 2020, we are proud to receive multiple regulatory approvals and gain market access in various continents and countries. With our goal to bring advanced AI tech for the unmet clinical demands in healthcare, we'll continue to deliver value to the global medical community.

Thank you @AuntMinnie for awarding our InferRead Lung CT.AI as the Best New Radiology Software at the Minnies 2020 Award! We are honored to be recognized by the radiology community. Infervision will continue to deliver great products and services to our clients.

We appreciate the honor from AuntMinnies.com and the radiology community to vote Infervision's InferRead Lung CT.AI as the ‘Best New Radiology Software’ this year! We will continue to bring excellent AI solutions to the medical communities worldwide.

Infervision has now joined forces with Nuance Communications @NuanceInc to better assist healthcare providers for an optimized workflow with improved diagnosis efficiency and accuracy. Learn more about our collaboration: whatsnext.nuance.com/healthcare/inf…

While the mounting number of COVID-19 cases is quite concerning, it is encouraging to see AI's capabilities and potential to help the medical communities worldwide battle this pandemic. Infervision's AI is always standby to provide high-quality assistance for health providers.

The research published at The Lancet Digital Health regarding DL-based triage and analysis of lesion burden for COVID-19 has demonstrated the ability and efficacy of AI in expediting identification of chest CT scans with imaging indications of COVID-19. thelancet.com/journals/landi…

Infervision is named at the global #DigitalHealth150 List by CB Insights. We are honored for the recognition of our work and efforts in bringing advanced AI solutions to the medical communities worldwide. cbinsights.com/research/repor…

This research study pushes the boundary forward in the field of AI for cancer immunotherapy. It concludes that CT features were significantly associated with the PD-L1 expression status. Compared to morphologic CT features, DL-3D DenseNet Model improves the prediction efficacy.

Infervision is proud to announce that our team has completed a research study that introduces a novel pipeline for predicting the PD-L1 expression in patients with lung adenocarcinomas using our deep learning-enabled platform. Check out the details: bit.ly/ct-pdl1

We are pleased to announce that Infervision receives FDA clearance for the InferRead Lung CT.AI product. Learn more about this deep learning-based product for chest CT at us.infervision.com/news/68.html

We are excited to be the panelist for Health Innovation Exchange #HIEx2020 on the session: 'Bridging the Gap: How can we better connect Innovations, Investments and Community needs.' The event starts at 13:30 CET/7:30 EDT, Jul 2nd. Please join us soon at bit.ly/2BVBDjG.

🤖A Torino arriva l’Intelligenza Artificiale per combattere il Covid-19. Una tecnica rivoluzionaria a disposizione dei radiologi di @cittasalute_to e #unito, grazie all’accordo con @inferVISION, @EU_Commission e @CSP_live 👉unitonews.it/index.php/it/n…